FIBRINOLYTIC AND DEFIBRINATING EFFECT OF PHENFORMIN PLUS ETHYLŒSTRENOL IN VIVO
- 3 May 1969
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 293 (7601), 910-914
- https://doi.org/10.1016/s0140-6736(69)92545-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- EFFECT OF ETHYLŒSTRENOL COMBINED WITH PHENFORMIN OR WITH METFORMIN ON PLATELET STICKINESS AND SERUM-CHOLESTEROL IN PATIENTS WITH OCCLUSIVE VASCULAR DISEASEThe Lancet, 1968
- FIBRINOLYTIC ACTIVITY AND CORONARY-ARTERY DISEASEThe Lancet, 1968
- THERAPEUTIC DEFIBRINATION IN THE TREATMENT OF THROMBOTIC DISEASEThe Lancet, 1968
- FIBRINOLYTIC EFFECTS OF DIGUANIDES PLUS ETHYLŒSTRENOL IN OCCLUSIVE VASCULAR DISEASEThe Lancet, 1967
- REDUCTION OF PLATELET STICKINESS BY PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1967
- GASTRIC FIBRINOLYSIS A Possible qtiological Link with Peptic UlcerThe Lancet, 1967
- FIBRINOLYTIC TREATMENT OF RHEUMATOID ARTHRITIS WITH PHENFORMIN PLUS ETHYLŒSTRENOLThe Lancet, 1966
- Measurement of spontaneous fibrinolytic activityJournal of Clinical Pathology, 1964
- A CONCEPT OF NATURAL FIBRINOLYSISThe Lancet, 1961
- THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSISThe Lancet, 1956